Clinical Trial Update: Imatinib in Dermatofibrosarcoma Protuberans (DFSP) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of imatinib for dermatofibrosarcoma protuberans has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatofibrosarcoma Protuberans

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Dermatologic Cooperative Oncology Group | Conditions: Dermatofibrosarcoma | Phase 1, Phase 2 | Status: COMPLETED